Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0 0
Stock impact report

Menlo Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results

MENLO THERAPEUTICS INC COMMON (MNLO) 
Last menlo therapeutics inc common earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.menlotherapeutics.com/investor-relations
Company Research Source: GlobeNewswire
REDWOOD CITY, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ:MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant, for the treatment of pruritus associated with various underlying dermatologic conditions and for refractory chronic cough, today announced financial results for the fourth quarter and year ended December 31, 2017 and provided an update on its clinical development programs. “We are extremely pleased with the completion of our initial public offering.  The funds from the IPO will provide Menlo the ability to advance the development of serlopitant as a potential once-daily therapy for pruritus and cough. We look forward to seeing the results from our Phase 2 study (ATOMIK) in atopic dermatitis which are expected in April of 2018,” stated Steve Basta, Chief Executive Officer of Menlo Therapeutics. Fourth Quarter Business Highlights and Recent Developments In January, we successfully completed our initial publ Show less Read more
Impact Snapshot
Event Time:
MNLO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for MNLO alerts
Opt-in for
MNLO alerts

from News Quantified
Opt-in for
MNLO alerts

from News Quantified